
James P. Dunn
Ophthalmology
840 Walnut Street
Floor 10
Philadelphia, PA 19107
Floor 10
Philadelphia, PA 19107
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Clinical Features and Visual Outcomes of Pediatric Noninfectious Posterior and Panuveitis.
Journal: Ocular immunology and inflammation
Published: August 28, 2026
Bilateral panuveitis associated with letrozole therapy.
Journal: Retinal cases & brief reports
Published: June 22, 2026
Clinical Outcomes of Ocular Toxoplasmosis-Associated Rhegmatogenous and Tractional Retinal Detachment.
Journal: Journal of vitreoretinal diseases
Published: May 18, 2026
Foveal Micro-embolism in Subacute Bacterial Endocarditis and the Emerging Role of Neutrophil Extracellular Traps: A Case Report and Review of the Literature.
Journal: Retinal cases & brief reports
Published: March 30, 2026
Characteristics of Uveitis Specialists and Disparities in Geographic Access to Uveitis Care in the United States.
Journal: Journal of vitreoretinal diseases
Published: January 02, 2026
REAL-WORLD INCIDENCE AND MANAGEMENT OF OCULAR HYPERTENSION AFTER SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE INJECTION FOR MACULAR EDEMA IN NONINFECTIOUS UVEITIS.
Journal: Retina (Philadelphia, Pa.)
Published: September 15, 2025
Green vessel signal on multicolor imaging as an early sign of ischemic vasculitis in IRVAN Syndrome: A case report.
Journal: American journal of ophthalmology case reports
Published: August 21, 2025
Incidence, Management, and Outcomes of Eyes with Comorbid Active Uveitis and Central Serous Chorioretinopathy.
Journal: Retina (Philadelphia, Pa.)
Published: April 04, 2025
Prolonged Undifferentiated Postoperative Pseudophakic Iridocyclitis.
Journal: Ophthalmology
Published: October 23, 2024
OUTCOMES OF PRO RE NATA VERSUS TREAT-AND-EXTEND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR MYOPIC MACULAR NEOVASCULARIZATION IN MULTIETHNIC PATIENTS IN THE UNITED STATES.
Journal: Retina (Philadelphia, Pa.)
Published: August 22, 2024
Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment.
Journal: Ophthalmology
Published: August 09, 2024
Last Updated: 09/26/2026